Literature DB >> 31146570

Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint infection.

N Khan1, D Parmar1, M S Ibrahim1, B Kayani1, F S Haddad2.   

Abstract

AIMS: The increasing infection burden after total hip arthroplasty (THA) has seen a rise in the use of two-stage exchange arthroplasty and the use of increasingly powerful antibiotics at the time of this procedure. As a result, there has been an increase in the number of failed two-stage revisions during the past decade. The aim of this study was to clarify the outcome of repeat two-stage revision THA following a failed two-stage exchange due to recurrent prosthetic joint infection (PJI). PATIENTS AND METHODS: We identified 42 patients who underwent a two-stage revision THA having already undergone at least one previous two stage procedure for infection, between 2000 and 2015. There were 23 women and 19 men. Their mean age was 69.3 years (48 to 81). The outcome was analyzed at a minimum follow-up of two years.
RESULTS: A satisfactory control of infection and successful outcome was seen in 26 patients (57%). There therefore remained persistent symptoms that either required further surgery or chronic antibiotic suppression in 16 patients (38%). One-third of patients had died by the time of two years' follow-up.
CONCLUSION: The rate of failure and complication rate of repeat two-stage exchange THA for PJI is high and new methods of treatment including host optimization, immunomodulation, longer periods between stages, and new and more powerful forms of antimicrobial treatment should be investigated. Cite this article: Bone Joint J 2019;101-B(6 Supple B):110-115.

Entities:  

Keywords:  Arthroplasty; Infection; Prosthetic joint infection; Total hip arthroplasty; Two-stage exchange

Mesh:

Year:  2019        PMID: 31146570     DOI: 10.1302/0301-620X.101B6.BJJ-2018-1556.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  6 in total

1.  Repeat two-stage exchange arthroplasty for recurrent periprosthetic hip or knee infection: what are the chances for success?

Authors:  A C Steinicke; J Schwarze; G Gosheger; B Moellenbeck; T Ackmann; C Theil
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-04       Impact factor: 3.067

2.  One-year infection control rates of a DAIR (debridement, antibiotics and implant retention) procedure after primary and prosthetic-joint-infection-related revision arthroplasty - a retrospective cohort study.

Authors:  F Ruben H A Nurmohamed; Bruce van Dijk; Ewout S Veltman; Marrit Hoekstra; Rob J Rentenaar; Harrie H Weinans; H Charles Vogely; Bart C H van der Wal
Journal:  J Bone Jt Infect       Date:  2021-01-27

3.  Synovial Fluid Interleukin-16 Contributes to Osteoclast Activation and Bone Loss through the JNK/NFATc1 Signaling Cascade in Patients with Periprosthetic Joint Infection.

Authors:  Yuhan Chang; Yi-Min Hsiao; Chih-Chien Hu; Chih-Hsiang Chang; Cai-Yan Li; Steve W N Ueng; Mei-Feng Chen
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

4.  Periprosthetic Joint Infection Caused by Gram-Positive Versus Gram-Negative Bacteria: Lipopolysaccharide, but not Lipoteichoic Acid, Exerts Adverse Osteoclast-Mediated Effects on the Bone.

Authors:  Mei-Feng Chen; Chih-Hsiang Chang; Chih-Chien Hu; Ying-Yu Wu; Yuhan Chang; Steve W N Ueng
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

5.  Does serum interleukin-6 guide the diagnosis of persistent infection in two-stage hip revision for periprosthetic joint infection?

Authors:  Peng-Fei Qu; Chi Xu; Jun Fu; Rui Li; Wei Chai; Ji-Ying Chen
Journal:  J Orthop Surg Res       Date:  2019-11-11       Impact factor: 2.359

6.  What is the appropriate extended duration of antibiotic prophylaxis after two-stage revision for chronic PJI?

Authors:  Xinyu Fang; Qiaojie Wang; Xurong Yang; Feiyang Zhang; Changyu Huang; Zida Huang; Hao Shen; Wenming Zhang
Journal:  Bone Joint Res       Date:  2021-12       Impact factor: 4.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.